Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults

NCT02719327 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT02719327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02719327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults
Lead sponsor
VA Office of Research and Development
Phase
Phase 2/3
Overall status
Completed
Start date
June 8, 2017
Completion date
September 29, 2023
Enrollment
131 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease